CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $70.22 | $154K | 0 |
| 2025-04-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 1,800 | ||
| 2025-04-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +590 | $5.05 | $3K | 86,212 |
| 2025-04-01 | Maduck Sean See Remarks | Sale 10b5-1 | −590 | $114.55 | $68K | 85,622 |
| 2025-04-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −590 | 121,396 | ||
| 2025-04-01 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +650 | $13.56 | $9K | 9,659 |
| 2025-04-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −650 | $114.53 | $74K | 9,009 |
| 2025-04-01 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −650 | 55,921 | ||
| 2025-04-01 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +678 | $21.65 | $15K | 6,165 |
| 2025-04-01 | Guyer William Chief Development Officer | Sale 10b5-1 | −678 | $114.51 | $78K | 5,487 |
| 2025-04-01 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −678 | 449,322 | ||
| 2025-04-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −350 | $114.71 | $40K | 2,981,985 |
| 2025-03-31 | Maduck Sean See Remarks | Option exercise 10b5-1 | +100,000 | $8.27 | $827K | 185,622 |
| 2025-03-31 | Maduck Sean See Remarks | Sale 10b5-1 | −79,277 | $100.26 | $7.9M | 106,345 |
| 2025-03-31 | Maduck Sean See Remarks | Sale 10b5-1 | −15,133 | $101.43 | $1.5M | 91,212 |
| 2025-03-31 | Maduck Sean See Remarks | Sale 10b5-1 | −5,590 | $102.16 | $571K | 85,622 |
| 2025-03-31 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −100,000 | 300,000 | ||
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +35,000 | $13.56 | $475K | 44,009 |
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +75,000 | $16.52 | $1.2M | 119,009 |
| 2025-03-31 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +40,000 | $15.82 | $633K | 159,009 |
Page 28 of 61 · 1,220 trades